T. Rowe Price Associates, Inc. 13D and 13G filings for Alexion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN | T. Rowe Price Associates, Inc. | 1,536,173 0.700% | -10,569,725 (-87.31%) | Filing |